Jump to main content
Jump to site search

Issue 2, 2015
Previous Article Next Article

Protein–polymer therapeutics: a macromolecular perspective

Author affiliations

Abstract

The development of protein–polymer hybrids emerged several decades ago with the vision that their synergistic combination will offer macromolecular hybrids with manifold features to succeed as the next generation therapeutics. From the first generation of protein–polymer therapeutics represented by PEGylated proteins, the field has since advanced, reinforced by the progress in contemporary chemical techniques for designing polymeric scaffolds and protein engineering. Novel polymerization techniques that offer multifunctional strategies as well as a greater understanding of proteins and their biological behavior have both proven to be exceptional tools in the construction of these hybrid materials. In this review, we seek to summarize and highlight the recent progress in these semi-synthetic protein hybrids in terms of their preparation, design, resulting bioarchitectures and bioactivities for their intended bio-applications.

Graphical abstract: Protein–polymer therapeutics: a macromolecular perspective

Back to tab navigation

Publication details

The article was received on 30 Jul 2014, accepted on 09 Sep 2014 and first published on 13 Oct 2014


Article type: Review Article
DOI: 10.1039/C4BM00270A
Citation: Biomater. Sci., 2015,3, 214-230
  •   Request permissions

    Protein–polymer therapeutics: a macromolecular perspective

    Y. Wu, D. Y. W. Ng, S. L. Kuan and T. Weil, Biomater. Sci., 2015, 3, 214
    DOI: 10.1039/C4BM00270A

Search articles by author

Spotlight

Advertisements